<DOC>
	<DOCNO>NCT01402492</DOCNO>
	<brief_summary>The aim study investigate safety effectiveness buprenorphine presence naltrexone treatment cocaine dependence .</brief_summary>
	<brief_title>Cocaine Use Reduction With Buprenorphine</brief_title>
	<detailed_description>This project assess utility buprenorphine presence naltrexone potential medication useful reduce cocaine use , commence research direction great importance theoretical practical addiction medicine . Buprenorphine provide sublingual buprenorphine+naloxone tablet ( Suboxone® , `` BUP '' ) . Naltrexone provide extended-release naltrexone injection ( Vivitrol® , `` XR-NTX '' ) . In multi-center , double-blind , placebo-controlled trial , participant randomly assign one three medication condition : 4mg buprenorphine plus naltrexone ( BUP4+XR-NTX ) , 16mg buprenorphine plus naltrexone ( BUP16+XR-NTX ) , placebo plus naltrexone ( PLB+XR-NTX ) 8 week treatment . Participants schedule clinic visit three time weekly ( total 24 visit across 8-week treatment period ) observe medication administration , provision take-home medication , collection safety , medical , drug use , psychological , compliance measure . In addition , participant schedule once-weekly individual Cognitive Behavioral Therapy ( CBT ) session . This protocol explore effect three medication condition test buprenorphine possible treatment cocaine dependence . This study advance science , provide dose information , characterize effect combination two medication population .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>18 65 year age In good general health Meet DSMIV criterion cocaine dependence Meet DSMIV criterion pastyear opioid dependence OR pastyear opioid abuse OR pastyear opioid use history opioid dependence lifetime Interested receiving treatment cocaine dependence Able speak English sufficiently understand study procedure provide write informed consent participate study Able satisfy comply study procedures requirement If female childbearing potential , willing practice effective method birth control duration study Pregnant breastfeeding female Known allergy sensitivity study medication Recent ongoing treatment medication , judgment study medical clinician , could interact adversely study drug interfere study participation Have current pattern alcohol , benzodiazepine , sedativehypnotic use , determine study medical clinician , would preclude safe participation Liver function test result great 5 time upper limit normal exclusionary clinical lab test value Serious medical condition acute psychiatric disorder would make study participation difficult unsafe Pending action situation might prevent remain area duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Cocaine-Related disorder</keyword>
	<keyword>Cocaine</keyword>
	<keyword>Substance-Related disorder</keyword>
	<keyword>Opioid abuse</keyword>
	<keyword>Opioid dependence</keyword>
	<keyword>abuse</keyword>
	<keyword>addiction</keyword>
	<keyword>treatment</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>naltrexone</keyword>
	<keyword>Suboxone</keyword>
	<keyword>Vivitrol</keyword>
</DOC>